TH3890B - Vaccines for hepatitis type B - Google Patents
Vaccines for hepatitis type BInfo
- Publication number
- TH3890B TH3890B TH8401000321A TH8401000321A TH3890B TH 3890 B TH3890 B TH 3890B TH 8401000321 A TH8401000321 A TH 8401000321A TH 8401000321 A TH8401000321 A TH 8401000321A TH 3890 B TH3890 B TH 3890B
- Authority
- TH
- Thailand
- Prior art keywords
- hepatitis
- rebar
- type
- vaccines
- antigen
- Prior art date
Links
- 208000002672 hepatitis B Diseases 0.000 title abstract 4
- 229960005486 vaccine Drugs 0.000 title 1
- 230000002363 herbicidal effect Effects 0.000 claims 1
- 239000004009 herbicide Substances 0.000 claims 1
- 239000000427 antigen Substances 0.000 abstract 3
- 102000036639 antigens Human genes 0.000 abstract 3
- 108091007433 antigens Proteins 0.000 abstract 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 abstract 2
- 229910052782 aluminium Inorganic materials 0.000 abstract 2
- 239000003381 stabilizer Substances 0.000 abstract 2
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- SPSXSWRZQFPVTJ-ZQQKUFEYSA-N hepatitis b vaccine Chemical compound C([C@H](NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](CC1N=CN=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)OC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](N)CCCNC(N)=N)C1=CC=CC=C1 SPSXSWRZQFPVTJ-ZQQKUFEYSA-N 0.000 abstract 1
- 229940124736 hepatitis-B vaccine Drugs 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Abstract
การเตรียมวัคซีนสำหรับตับอักเสบชนิด B ด้วยวิธีไลโอฟิไลส์,ซึ่งประกอบด้วยสารที่ทำให้เสถียรและแอนทีเจนสำหรับตับอักเสบชนิด B ที่มีไวรัสอยู่ที่ผิว ซึ่งได้ทำให้บริสุทธิ์,ไม่ว่องไว ได้ถูกดูดซับอยู่อะลูมินัมเจล ซึ่งเตรียมได้โดยการเติมอะลูมินัมเจลและสารที่ทำให้เสถียรลงในแอนทิเจนสำหรับตับอักเสบชนิด B ที่มีไวรัสอยู่ที่ผิวและทำไลโอฟิไลส์ของผสมนี้ การเตรียมด้วยวิธีทำไลโอฟิไลส์ดังกล่าวนี้เสถียรสามารถเก็บเอาไว้ในช่วงเวลายาวโดยปราศจากการสูญเสียกำลังแรงของแอนทิเจนและใช้ประโยชน์สำหรับป้องกันการติดเชื้อโรคไวรัสสำหรับตับอักเสบชนิด B สิทธิบัตรยา A lyophilized hepatitis B vaccine preparation, containing stabilizers and antigens for hepatitis B with the virus on the surface. Purified Has been absorbed in the aluminum gel It was prepared by adding aluminum gel and stabilizer to the antigen for viral hepatitis B type on the surface and by lyophilizing the mixture. This lyophilized preparation is stable, can be stored over a long period of time without antigen depletion and is used for the prevention of viral infection for hepatitis B type. Drug patent
Claims (1)
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TH2141A TH2141A (en) | 1985-01-02 |
| TH3890B true TH3890B (en) | 1994-07-29 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LU90911I2 (en) | Recombinant antigen comprising the pre-S1 and S sequences of the hepatitis B virus active ingredient of hepacare | |
| ES2061500T5 (en) | DIAGNOSIS AND VACCINES OF DELTA HEPATITIS, ITS PREPARATION AND USE. | |
| IE38825L (en) | Stabile viral preparation | |
| DE3789399D1 (en) | Production of vaccines against hepatitis B virus. | |
| ZA853026B (en) | Leukemia-associated virus immunogen,vaccine and assay | |
| CA2186044A1 (en) | Novel mutated viruses, anti-viral compounds and novel methods of making vaccines | |
| Woodhour et al. | Hyperpotentiation by synthetic double-stranded RNA of antibody responses to influenza virus vaccine in adjuvant 65 | |
| CO4480039A1 (en) | RECOMBINANT FELINE IMMUNODEFICIENCY VACCINES PRODUCED IN BACULOVIRUSES AND THEIR USE AGAINST INFECTION WITH FELINE IMMUNODEFICIENCY VIRUSES | |
| Zanetti et al. | Hepatitis B vaccination of 113 hemophiliacs: Lower antibody response in anti‐LAV/HTLV‐III‐positive patients | |
| Tabor et al. | Removal of hepatitis-B-virus infectivity from Factor-IX Complex by hepatitis-B immune-globulin: experiments in chimpanzees | |
| ES8201020A1 (en) | Feline infectious peritonitis virus, its preparation and vaccines containing it. | |
| TH3890B (en) | Vaccines for hepatitis type B | |
| SE9202968L (en) | New peptides, diagnostic antigens, their use, vaccines and drugs | |
| Heijtink et al. | Hepatitis B vaccination in Down's syndrome and other mentally retarded patients | |
| MX9102757A (en) | VACCINE OF MAREK'S DISEASE VIRUS WITHOUT CELLS. | |
| FI890116A0 (en) | ICKE-REVERTERANDE RNA VIRUS. | |
| IE891296L (en) | A synthetic vaccine against foot and mouth disease and a¹process for the preparation thereof | |
| EP0255242A3 (en) | Oncornavirus vaccines | |
| Loebenstein et al. | Plant defense responses to viral infections. | |
| ES515472A0 (en) | PROCEDURE TO PROTECT SUSCEPTIBLE HOSTS FROM HEPATITIS INFECTION. | |
| Bader | Hepatitis B in prisons | |
| Morfini et al. | Hepatitis B Vaccination of 113 | |
| Fourcade et al. | Protective Effect of Immunization with Polyinosinic· Polycytidylic Acid Complexed with Methylated Bovine Serum Albumin against Friend Leukemia Virus in Mice | |
| SU1580617A1 (en) | Method of preparing vaccine against influenza virus | |
| Zourbas et al. | Immunization of dental surgeons against hepatitis B virus infection. |